cytochrome c reductase type i
9027-14-9
|
(RS)-C-(3,4-dichloro-phenyl)-C-phenyl-methylamine
742107-55-7
|
Appenolide C
148077-12-7
|
erythromycin C
1675-02-1
|
1-C,3-C,5-C-Tris(3-methyl-2-butenyl)-scyllo-inositol
69790-33-6
|
pyrayaquinone C
117591-99-8
|
agglomerin C
125620-72-6
|
dimethyl c-3-(2'-methylphenyl)cyclohex-4-ene-r-1,c-2-dicarboxylate
144152-90-9
|
homofascaplysin C
132911-52-5
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
(1R,3AR,7aR)-7a-methyl-1-((R)-6-methyl-6-((trimethylsilyl)oxy)heptan-2-yl)-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl trifluoromethanesulfonate
222317-53-5
|
tert-Butyl-DL-alanine
1375289-11-4
|
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
|
